Ultravist: Safety and Efficacy in Computed Tomography of Head and Body

Completed · Phase 3

Conditions studied: Computed Tomography, Diagnostic Imaging

In brief

This is a research study involving the use of a contrast agent called Ultravist Injection. Ultravist, the study drug, is used to improve the pictures obtained using computed tomography (CT). Ultravist acts like a dye to make CT pictures brighter and easier to read. In the case of this study, it will be injected into a vein in the patient's arm; from there, it travels through the blood stream and to the areas to be examined. CT scans will then be taken of the patient's head and/or body as ordered by his/her physician. Phase IIIb Study to Document the Safety and Efficacy of Ultravist 370 mg I/ml, When Administered Intravenously, in Volumes up to 162.2 ml, for Clinically Indicated Contrast Enhanced Computed Tomography (CECT) of the Head and/or Body

Key facts

Study ID

NCT00244140

Run by

Bayer

People needed

435

Starts

2005-10-01

Expected to finish

2008-04-01

Last updated by the study team

2014-02-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Is at least 18 years old and clinically indicated for a contrast-enhanced CT of the head or body.

You may not qualify if…

• Patients that are less than 18 years old and do not have a clinical indication for a contrast-enhanced CT of the head or body.

Where it is running

• Study site — Tucson, Arizona, United States
• Study site — Miami, Florida, United States
• Study site — Tallahassee, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Atlanta, Georgia, United States
• Study site — Evanston, Illinois, United States
• Study site — Baltimore, Maryland, United States
• Study site — Boston, Massachusetts, United States
• Study site — Boston, Massachusetts, United States
• Study site — Boston, Massachusetts, United States
• Study site — Ann Arbor, Michigan, United States
• Study site — Detroit, Michigan, United States
• Study site — New York, New York, United States
• Study site — Stony Brook, New York, United States
• Study site — Cleveland, Ohio, United States
• Study site — Danville, Pennsylvania, United States
• Study site — Charleston, South Carolina, United States
• Study site — Medellín, Antioquia, Colombia
• Study site — Bogotá, Colombia
• Study site — Mumbai-400026, India
• Study site — Tamil Nadu, India
• Study site — Seoul, Seoul Teugbyeolsi, South Korea
• Study site — Seoul, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.